Stent :: Safety of carotid stenting in ‘real-world’ setting

The largest-ever study of carotid stenting in high-surgical risk patients has shown that with proper education and training, community physicians are just as successful at using catheter-based techniques to unclog arteries supplying blood to the brain as are those who pioneered the procedure at major university medical centers.

Lead :: Pros and cons of therapy for lead exposure

Lead chelation therapy can lessen learning and behavioral problems due to lead exposure, but the therapy adversely affected rats with no lead in their systems, a Cornell study shows. The finding has implications for the treatment of autistic children.

Healthcare :: Licensing Opportunities for Rare Disease Technologies

The National Institutes of Health (NIH) launched a new website today offering technologies available for commercial licensing that are related to rare diseases or conditions. The listing can be found at http://www.ott.nih.gov/rarediseases and currently consists of more than 500 such technologies, including drugs, biologics, and devices, available to be transferred from the NIH and the U.S. Food and Drug Administration (FDA) to the private sector for further research and development and potential commercialization.

Nystagmus :: Leicester breakthrough in eye disease

Researchers at the University of Leicester have identified for the first time a gene which causes a distressing eye condition. Their discovery, as reported in the journal Nature Genetics, is expected to lead to better treatments for the condition.

Brain :: Mandarin language is music to the brain

It’s been shown that the left side of the brain processes language and the right side processes music; but what about a language like Mandarin Chinese, which is musical in nature with wide tonal ranges?

Alzheimer’s Disease :: Protein fingerprint in spinal fluid could spot Alzheimer’s disease

Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical “fingerprint,” which doctors might use someday to identify patients living with Alzheimer’s disease. The research will be published in the December online edition of the journal Annals of Neurology.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack